| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/04/2004 | WO2002102848A3 Nucleic acid and amino acid sequences of a vegf variant |
| 03/04/2004 | WO2002100900A3 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof |
| 03/04/2004 | WO2002099092A3 Production of recombinant human lysosomal alpha-mannosidase |
| 03/04/2004 | WO2002092818A8 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets |
| 03/04/2004 | WO2002092762A3 Cytokine polypeptides |
| 03/04/2004 | WO2002090565A3 Magnetic beads and uses thereof |
| 03/04/2004 | WO2002090536A3 A method for producing recombined polynucleotides |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | WO2002083075A3 Akt and regulation of ra synovial fibroblast apoptosis |
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | WO2002081746A3 A method for identifying constitutively active mutants of mitogen activated protein kinases (mapk) and uses thereof |
| 03/04/2004 | WO2002079495A3 Genomics applications for modified oligonucleotides |
| 03/04/2004 | WO2002079477A3 Biosynthetic genes for butenyl-spinosyn insecticide production |
| 03/04/2004 | WO2002079467A3 Antibiotic-free bacterial strain selection with antisense molecules |
| 03/04/2004 | WO2002078640A3 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 03/04/2004 | WO2002063951A3 Human disease modeling using somatic gene transfer |
| 03/04/2004 | WO2002036780A8 Stearoyl-coa desaturase gene promoter |
| 03/04/2004 | WO2002029032A3 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002020748A8 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof |
| 03/04/2004 | WO2002014352A9 Therapeutic compounds for ovarian cancer |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | WO2002002811B1 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 03/04/2004 | WO2001073123B1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/04/2004 | WO2001057276A9 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow |
| 03/04/2004 | WO1995028959A9 MICE MUTANT FOR Fc RECEPTORS AND METHOD OF TREATING AUTOIMMUNE DISEASE |
| 03/04/2004 | US20040045059 Rice hybrid RH101 |
| 03/04/2004 | US20040045056 Transformation of Brassica |
| 03/04/2004 | US20040045055 Gene for a Dof transcription factor capable of altering the size and stature of a plant |
| 03/04/2004 | US20040045054 Comprises nucleotide sequences coding insectidal protein for generating lepidopteran resistant cotton; genetic mapping |
| 03/04/2004 | US20040045053 Comprises expression vector coding tissue specific regulatory sequences and polypeptides which inrease crop yields, improve nutritional value of pollen, confer herbicide resistance and controlling fertility in plants |
| 03/04/2004 | US20040045052 Maize Rar1 polynucleotides and methods of use |
| 03/04/2004 | US20040045051 Comprises nucleotide sequences coding phytol kinase associated with vitamin e and tocotrienol biosynthesis for diagnosis, prevention and treatment of cardiovascular and cancer diseases |
| 03/04/2004 | US20040045050 Methods and materials for transformation |
| 03/04/2004 | US20040045049 Trangenic heat, freeze, drought and disease resistant plants |
| 03/04/2004 | US20040045048 Method for plant gene transferring by micro-vibration and ovary injection |
| 03/04/2004 | US20040045047 Method for plant gene transfering by electrical shock and ovary injection |
| 03/04/2004 | US20040045046 Transgenic mammals expressing polyglutamine |
| 03/04/2004 | US20040045043 Comprises expression vectors for generating transgenic animal models for screening drugs and treating obesity and cardiovascular disorders |
| 03/04/2004 | US20040045041 Means for the identification compounds capable of inhibiting karap-transduced signals |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044193 C. albicans tec1 gene (catec1) and the coded tecip protein |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044187 Chimeric immunoglobulin for prevention and treatment blood, tumor, cardiovascular and urogenital disorders |
| 03/04/2004 | US20040044185 Comprises transmembrane protein for use in liposome-based drug and nucleotide delivery systems; gene therapy |
| 03/04/2004 | US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases |
| 03/04/2004 | US20040043958 Glucocorticoid enhancement of gene expression |
| 03/04/2004 | US20040043957 Antisense modulation of urokinase plasminogen activator expression |
| 03/04/2004 | US20040043956 Hybrid nucleic acid; skin disorders; antiinflammatory agents |
| 03/04/2004 | US20040043954 Liposomes |
| 03/04/2004 | US20040043953 Genetic engineering; culture product |
| 03/04/2004 | US20040043950 Oligonucleotide antibodies; anticancer agents; measurement gene expression in sample; calibration |
| 03/04/2004 | US20040043948 Hybrid nucleic acids |
| 03/04/2004 | US20040043939 Peptide-based gemini compounds |
| 03/04/2004 | US20040043932 Leptin-related peptides |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043924 Uses of keratinocyte growth factor-2 |
| 03/04/2004 | US20040043923 Detection, calibration binding of ligand to nucleic acids |
| 03/04/2004 | US20040043921 Substances and their uses |
| 03/04/2004 | US20040043491 Penicillin production using transgenic merodiploid strains |
| 03/04/2004 | US20040043490 Cells to be used in producing virus vector, process for producing the same, and process for producing virus vector with the use of the cells |
| 03/04/2004 | US20040043489 Gene delivery vectors provided with a tissue tropism for dendritic cells and methods of use |
| 03/04/2004 | US20040043488 Adeno-associated viral gene-transfer vector system |
| 03/04/2004 | US20040043487 Generating trangenic embryonic stem cells using vector insertional mutagenesis and nuclear transplantation |
| 03/04/2004 | US20040043486 Inserting exogenous nucleotide sequences into genome of target mammalian cells using transpoases |
| 03/04/2004 | US20040043485 Transposable elements in rice and methods of use |
| 03/04/2004 | US20040043471 Production of chimeric human papillomavirus |
| 03/04/2004 | US20040043470 Regulation of human histone deacetylase |
| 03/04/2004 | US20040043468 Synthetic translational regulatory elements for controlling translation of preferential polypeptides; gene therapeutic tools |
| 03/04/2004 | US20040043467 Supracolonic aerodigestive neoplasm detection |
| 03/04/2004 | US20040043465 Method of screening compounds that inhibit lysophosphatidic acid acyltransferase |
| 03/04/2004 | US20040043464 Comprises nucleotide sequences coding oligosaccharide biosynthetic enzymes for use as tools in genetic engineering and detection of neisseria infections |
| 03/04/2004 | US20040043463 Comprises inhibitory fusion protein topical for treating aberration affecting hair pigmentation, skin pigmentation and/or skin conditioning |
| 03/04/2004 | US20040043460 Process for producing optically active pyridineethanol derivatives |
| 03/04/2004 | US20040043459 Racemization and deprotection of special N-protected amino acids in the acylase/racemase system for the total conversion of special N- protected racemic amino acids into optically pure amino acids |
| 03/04/2004 | US20040043457 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/04/2004 | US20040043456 Novel compounds |
| 03/04/2004 | US20040043455 Methods for producing mammalian trypsins |
| 03/04/2004 | US20040043454 Growth arrest homeobox gene |
| 03/04/2004 | US20040043449 Comprises nucleotide sequences dihyroxy acetone phosphate acyltransferase (DHAP) and glycerol-3-phosphate (G-3-P) acyltransferase activities for modifying lipid/oil composition in higher plants |
| 03/04/2004 | US20040043444 Fermentation process using specific oxygen uptake rates as a process control |
| 03/04/2004 | US20040043437 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo |
| 03/04/2004 | US20040043432 Comprises soluble chimeric derivative of decay accelerating factor (DAF) for treating inflammatory and immune disorders |
| 03/04/2004 | US20040043418 Humanized antibodies that sequester Abeta peptide |
| 03/04/2004 | US20040043416 Using oligonucleotide ligation assay to identify restriction fragment lenth polymorphisms; high throughput assay for genotyping blood and bodily fluids and tissues |
| 03/04/2004 | US20040043411 DSP-11 dual-specificity phosphatase |
| 03/04/2004 | US20040043406 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 03/04/2004 | US20040043404 A chemical moiety that prohibits recrystallization of a denatured DNAportion |
| 03/04/2004 | US20040043402 Interferon-alpha induced gene |
| 03/04/2004 | US20040043400 Zygomycetes-derived endoglucanase enzyme lacking cellulose-binding domain |
| 03/04/2004 | US20040043399 Regulation of human inositolpolyphosphate 5-phosphatase |
| 03/04/2004 | US20040043396 Recombinant terminal deoxynucleotidyl transferase with improved functionality |
| 03/04/2004 | US20040043394 Arylhydrocarbon receptor (AhR) |
| 03/04/2004 | US20040043392 Selecting a specific cell or cells to be analyzed from a specimen on a substrate by using a laser; and isolating the cell or cells to be analyzed |
| 03/04/2004 | US20040043391 Leptospira vaccine antigens for the prevention of Leptospirosis |
| 03/04/2004 | US20040043383 Method and probes for the detection of chromosome aberrations |
| 03/04/2004 | US20040043381 Multiple sclerosis associated retrovirus (MSRV) -1 ; long terminal repeat sequences (LTR) |
| 03/04/2004 | US20040043375 Regulation of human serine-threonine protein kinase |